View printer-friendly version << Back
MEDNAX Announces Acquisition of Anesthesiology Practice in Georgia

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May. 1, 2013-- MEDNAX, Inc., (NYSE:MD) today announced the acquisition of Gwinnett Anesthesia Service, P.C., a physician group practice based in Lawrenceville, Georgia. The practice provides anesthesia services at Gwinnett Medical Center in Lawrenceville and Duluth, as well as at surgery centers and other outpatient facilities throughout those metropolitan areas. The practice will become part of MEDNAX’s American Anesthesiology division and is the third Georgia-based practice to join the company.

Gwinnett Anesthesia was founded in 1983 and is a private group practice consisting of 22 anesthesiologists, 59 anesthetists and 4 other clinical and administrative support staff, providing anesthesia services across a wide spectrum of subspecialty areas, including obstetric, cardiology, gynecology, general surgery and orthopedic care, as well as acute and chronic pain management services at its hospital and outpatient facilities.

“As physicians, our focus is always on our patients, so partnering with a national medical group with 30 years of business expertise, defined office infrastructure, and a commitment to research, education, and quality gives us the ability to maintain that focus,” said Larry Goldstein, M.D. who will serve as medical director for the practice. “Given the uncertainties in healthcare, we look forward to the stability and growth that comes with being part of American Anesthesiology.”

MEDNAX’s American Anesthesiology division consists of more than 1,575 anesthesia providers, including more than 650 physicians and 925 anesthetists practicing in North Carolina, Florida, Georgia, Michigan, New Jersey, Tennessee, Texas, and Virginia.

This practice was acquired for cash and the transaction is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.


MEDNAX, Inc. is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 330 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, MEDNAX expanded into anesthesia services. Today, American Anesthesiology includes more than 1,575 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs more than 2,150 physicians in 34 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

David T. Parker, 954-384-0175, Ext. 5300
Vice President, Investor Relations & Corporate Communications